Boticas Perú owner buys Pastipan bakery chain in food push
What's the deal? SYASA, the company behind Peru's Boticas Perú pharmacy chain, has acquired 100% of bakery and pastry chain Pastipan. The transaction closed on November 2, bringing a brand with more than 25 years of history under the Yrribarren family. Financial terms were not disclosed.
What's included? The deal covers Pastipan's brand, production facility, and 17 stores across Lima districts including San Borja, La Molina, and Santiago de Surco, according to ATV – Atrevámonos.
Why now? The purchase ends the involvement of the Fortaleza I fund, managed by MacrocapitalesDealroom has a profile for this one. Try Dealroom →, which bought a majority stake in Pastipan in 2016 for $11.46 million and had been looking to divest. Under the fund, the chain grew from 11 to 17 locations.
What's the endgame? The family is consolidating its interests — from pharmaceuticals to gastronomy — under a new group, Grupo Yrsa, as reported by Gestión. The group now runs six companies, including the chicharronería chain Kio, which lifted revenue 50% in 2025 to about S/ 25 million, plus health firms BMC Farma and the Doctor Perú polyclinic.
"We are always looking at related businesses and chances to grow our portfolio," said Adrián Yrribarren, president of the board of Grupo Yrsa, in an interview with Gestión (translated from Spanish).
What changes? Not much, for now. The new owners plan no rebrand, focusing instead on operational integration with Kio, such as specific bread sizes for sandwiches and shared produce logistics. Two new Pastipan openings are under review for next year, potentially in Miraflores and San Isidro.
What's the backstory? The family spent six months on due diligence after two earlier sale attempts collapsed over pricing. "Due diligence is very tedious. You have to check everything for your own safety, especially if there have been two failures," Yrribarren told Gestión (translated from Spanish).
The expansion angle: The pharmacy business stays the group's core. Boticas Perú ran 361 locations as of September 2026, aims to top 370 by year-end, and targets 500 by 2027, with a push into provincial markets, according to El Comercio Perú.
The signal: The deal shows a Peruvian family business diversifying beyond its pharmacy roots, while a private equity fund exits on schedule. The result is a budding multi-sector group spanning health, retail, and food.
Read more: archyde.com
Image credit: Generated with Gemini